Gregory Fond | Director, External Innovation, Rare Diseases

Gregory Fond, Director, External Innovation, Rare Diseases, Sanofi

Greg is a member of the Strategy & Business Development organization of Sanofi.  He and his team inform the R&D strategy and oversee the search & evaluation activities of Sanofi Genzyme Rare Diseases.  His team’s work culminates with the launch of R&D collaborations and partnerships with academic research institutions, incubators and startups as well as biotech and pharma companies.  Greg is based in California where Sanofi Genzyme Rare Diseases has established and brought to fruition numerous partnerships over the years.  Prior to this role, Greg was the alliance manager of Sanofi’s strategic research alliances with Caltech, Scripps Genomic Medicine and Salk.
Greg is trained as a chemist and chemical engineer focused on applied research across chemical, material and biological sciences. He has hands-on experience in sales, marketing and business development with start-ups and global corporations. His prior entrepreneurial ventures involved bioinformatics, medical devices and therapeutics in dermatology, endocrinology, pulmonology and rheumatology.


World Orphan Drug Congress USA 2018 - Conference Day One @ 11:50

Navigating the rare disease innovation ecosystem and partnering for the long-term

  • Looking into new technology platforms and transformative new products
  • Nurturing relationships with academia, incubators, startups and biotechs to develop fruitful partnerships 
  • From due diligence to alliance management, realizing the potential of scientific innovation, and going beyond ROI

back to speakers